We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.79%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$121B
AUM Growth
+$23.8B
(+25%)
Cap. Flow
+$14B
Cap. Flow
% of AUM
11.54%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
3,434
New
284
Increased
1,844
Reduced
1,127
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$345M |
| 2 |
PNC Financial Services
PNC
|
+$325M |
| 3 |
Edison International
EIX
|
+$249M |
| 4 |
Veeva Systems
VEEV
|
+$241M |
| 5 |
Expedia Group
EXPE
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$300M |
| 2 |
Comcast
CMCSA
|
+$255M |
| 3 |
Airbnb
ABNB
|
+$201M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$177M |
| 5 |
Eli Lilly
LLY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25% |
| 2 | Financials | 15.05% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Healthcare | 12.08% |
| 5 | Industrials | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Pliant Therapeutics
PLRX
$64.4M
| $62.3K | ﹤0.01% |
53,683
-18,374
| -25% | -$26K |
|
3227
Evolution Petroleum
EPM
$134M
| $61.2K | ﹤0.01% |
13,022
-4,613
| -26% | -$20.9K |
|
3228
Telos
TLS
$302M
| $60.8K | ﹤0.01% |
19,194
+2,699
| +16% | +$7.01K |
|
3229
Cardiff Oncology
CRDF
$80.1M
| $59.6K | ﹤0.01% |
18,921
-10,262
| -35% | -$31.3K |
|
3230
NET Power
NPWR
$139M
| $57.7K | ﹤0.01% |
+23,376
| New | +$49.1K |
|
3231
Achieve Life Sciences
ACHV
$685M
| $57.2K | ﹤0.01% |
25,300
+13,498
| +114% | +$38.4K |
|
|
MODV
3232
DELISTED
ModivCare
MODV
| $56K | ﹤0.01% |
17,937
-215,076
| -92% | -$396K |
|
3233
Commercial Vehicle Group
CVGI
$134M
| $54.7K | ﹤0.01% |
32,977
+14,589
| +79% | +$17.7K |
|
|
FLNA
3234
Filana Therapeutics
FLNA
$48.2M
| $53.9K | ﹤0.01% |
29,782
-50,162
| -63% | -$89.3K |
|
3235
Acumen Pharmaceuticals
ABOS
$176M
| $53.7K | ﹤0.01% |
46,292
+4,557
| +11% | +$4.9K |
|
3236
Rackspace Technology
RXT
$1.2B
| $50.3K | ﹤0.01% |
39,288
-225,277
| -85% | -$293K |
|
3237
X4 Pharmaceuticals
XFOR
$421M
| $50.1K | ﹤0.01% |
26,382
+23,483
| +810% | +$96.1K |
|
3238
Clover Health Investments
CLOV
$2.43B
| $49.5K | ﹤0.01% |
17,754
+4,178
| +31% | +$13.7K |
|
3239
Cabaletta Bio
CABA
$457M
| $48.8K | ﹤0.01% |
32,129
-41,827
| -57% | -$65.2K |
|
|
FSP
3240
Franklin Street Properties
FSP
$45.3M
| $47.7K | ﹤0.01% |
29,097
+16,457
| +130% | +$27.4K |
|
|
GCTS
3241
GCT Semiconductor Holding
GCTS
$225M
| $47.4K | ﹤0.01% |
31,823
+13,672
| +75% | +$18.5K |
|
|
AKYA
3242
DELISTED
Akoya BioSciences
AKYA
| $47.3K | ﹤0.01% |
36,409
+11,152
| +44% | +$13.4K |
|
3243
Cadiz
CDZI
$279M
| $44.5K | ﹤0.01% |
14,881
-12,111
| -45% | -$34.8K |
|
3244
LG Display
LPL
$3.36B
| $43.4K | ﹤0.01% |
+12,702
| New | +$39.3K |
|
3245
Entravision Communication
EVC
$1.08B
| $42.9K | ﹤0.01% |
18,508
+5,082
| +38% | +$10.3K |
|
3246
Omeros
OMER
$986M
| $41.6K | ﹤0.01% |
13,862
-20,838
| -60% | -$104K |
|
3247
Telomir Pharmaceuticals
TELO
$80.5M
| $41.5K | ﹤0.01% |
+33,234
| New | +$76.8K |
|
3248
Ranpak Holdings
PACK
$446M
| $41.2K | ﹤0.01% |
11,528
-11,161
| -49% | -$41.4K |
|
3249
Atossa Therapeutics
ATOS
$23.7M
| $40.1K | ﹤0.01% |
3,222
+2,139
| +198% | +$25.6K |
|
|
SCPH
3250
DELISTED
scPharmaceuticals
SCPH
| $40K | ﹤0.01% |
+10,491
| New | +$32.6K |
|
Similar funds
VGA
AQR Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, AQR Capital Management held 3,434 positions worth $121B, up 25% from $97.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $14B of net new capital in Q2 2025, opening 284 new positions and adding to 1,844 existing holdings. Its largest new stake was Reddit: 531,663 shares worth $80.1M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was ConocoPhillips, an estimated $300M trimmed.
- AQR Capital Management's largest Q2 2025 buy was Reddit: 531,663 shares worth $80.1M.
- AQR Capital Management added most to Monster Beverage in Q2 2025, an estimated $345M increase.
- AQR Capital Management's biggest Q2 2025 reduction was ConocoPhillips, cutting an estimated $300M.
- AQR Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $36.3M.
- AQR Capital Management's ten largest holdings make up 12% of its $121B portfolio in Q2 2025.
- AQR Capital Management opened 284 new positions and closed 142 in Q2 2025.
- AQR Capital Management's portfolio value rose 25% quarter-over-quarter to $121B.
Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.